{
  "id": "clinical#screening_cues_066bcf4f",
  "content": "methamfetamine and methcathinone\n6C47.Y Other specified disorder due to use of synthetic cathinones\nSubstance-induced mental disorders listed in other groupings\nDisorders due to substance use or addictive behaviours 499\n6C48.Y Other specified disorder due to use of caffeine\n6C49.Y Other specified disorder due to use of hallucinogens\n6C4A.Y Other specified disorder due to use of nicotine\n6C4B.Y Other specified disorder due to use of volatile inhalants\n6C4C.Y Other specified disorder due to use of MDMA or related drugs, including\nMDA\n6C4D.Y Other specified disorder due to use of dissociative drugs, including ketamine\nand PCP\n6C4E.Y Other specified disorder due to use of other specified psychoactive substance,\nincluding medications\n6C4F.Y Other specified disorder due to use of multiple specified psychoactive\nsubstances\n6C4G.Y Other specified disorder due to use of unknown or unspecified psychoactive\nsubstances\nEssential (required) features\n• The presentation is characterized by psychological, cognitive or behavioural symptoms that\ndevelop during or soon after intoxication with or withdrawal from a specified substance,\nor use or discontinuation of a psychoactive medication.\n• The symptoms do not fulfil the diagnostic requirements for any other disorder in the\ndisorders due to substance use grouping.\n• The intensity or duration of the symptoms is substantially in excess of disturbances that are",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues methamfetamine and methcathinone\n6C47.Y Other specified disorder due to use of synthetic cathinones\nSubstance-induced mental disorders listed in other groupings\nDisorders due to substance use or addictive behaviours 499\n6C48.Y Other specified disorder due to use of caffeine\n6C49.Y Other specified disorder due to use of hallucinogens\n6C4A.Y Other specified disorder due to use of nicotine\n6C4B.Y Other specified disorder due to use of volatile inhalants\n6C4C.Y Other specified disorder due to use of MDMA or related drugs, including\nMDA\n6C4D.Y Other specified disorder due to use of dissociative drugs, including ketamine\nand PCP\n6C4E.Y Other specified disorder due to use of other specified psychoactive substance,\nincluding medications\n6C4F.Y Other specified disorder due to use of multiple specified psychoactive\nsubstances\n6C4G.Y Other specified disorder due to use of unknown or unspecified psychoactive\nsubstances\nEssential (required) features\n• The presentation is characterized by psychological, cognitive or behavioural symptoms that\ndevelop during or soon after intoxication with or withdrawal from a specified substance,\nor use or discontinuation of a psychoactive medication.\n• The symptoms do not fulfil the diagnostic requirements for any other disorder in the\ndisorders due to substance use grouping.\n• The intensity or duration of the symptoms is substantially in excess of disturbances that are Methamfetamine and methcathinone\n6c47.y other specified disorder due to use of synthetic cathinones\nsubstance-induced mental disorders listed in other groupings\ndisorders due to substance use or addictive behaviours 499\n..."
}